SecBot SecBot
8-K ·Filed May 15, 2026

EMBC

Embecta Corp.
MIXED
Impact 6/10
Horizonweeks Processed5mo ago SEC0000947871-26-000546
8-K material event: Items 2.01
Actionable Insight ◆ Mixed

Monitor the upcoming 8-K/A filing (due within 71 days) for Owen Mumford's financial statements and pro forma impact on Embecta's balance sheet and revenue. The earn-out structure creates a binary catalyst around Aidaptus commercial milestones — any disclosure of initial sales traction or pharma partnerships will be a key sentiment driver. Given the all-cash structure and small market cap, watch for any subsequent equity or debt financing to replenish cash.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
EMBC ▲ +55.41% at T+60d
NEUTRAL call +55.41% · α vs SPY +50.90% · entry $3.14 → $4.88
Entry = T+0 close
May 15, 2026
via day close
T+1d
-3.50%
call -3.50% · α -3.44%
$3.03
settled 5mo ago
T+5d
+5.73%
call +5.73% · α +4.77%
$3.32
settled 5mo ago
T+20d
-0.32%
call -0.32% · α -2.44%
$3.13
settled 4mo ago
T+60d
+55.41%
call +55.41% · α +50.90%
$4.88
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Embecta Corp. completed its acquisition of Owen Mumford Holdings Limited for an upfront cash payment of £100 million (approximately $127 million at current exchange rates) plus up to £50 million in earn-out payments tied to Aidaptus auto-injector sales through June 2029. The deal accelerates Embecta's strategic pivot from insulin delivery into a broader chronic-care and drug-delivery platform company, but the all-cash consideration depletes a significant portion of Embecta's $186M market cap, raising leverage and integration risk.

Key Facts

  • Acquisition closed on May 15, 2026, for all issued share capital of Owen Mumford Holdings Limited.
  • Upfront cash payment of £100 million at closing, subject to customary adjustments for closing net cash.
  • Up to £50 million in additional earn-out payments based on commercial milestones for Aidaptus auto-injector platform through June 30, 2029.
  • Deal was originally announced on March 19, 2026, via a prior 8-K (Item 1.01).
  • Financial statements and pro forma financials will be filed by amendment within 71 calendar days.
  • Embecta's market cap is approximately $186 million, making the upfront cash consideration (~$127M) a substantial portion of equity value.

Financial Impact

Upfront cash payment of £100 million (~$127M) plus up to £50 million (~$63M) in earn-outs; total potential consideration up to ~$190M against a $186M market cap.

cashdebtrevenuedilution

Risk Factors

  • Integration risk — Owen Mumford is a UK-based private company; cultural and operational integration may be challenging.
  • Cash depletion — the £100M upfront payment represents a large cash outlay relative to Embecta's market cap, potentially straining liquidity.
  • Earn-out dependency — the £50M earn-out is tied to Aidaptus sales milestones, which are uncertain and may not materialize.
  • No financial statements yet — the 8-K defers filing of acquired company financials, leaving investors without visibility into Owen Mumford's revenue, profitability, or growth trajectory.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
11% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000947871-26-000546
Document: ss6329586_ex9901.htm0000947871-26-000546
Document: 0000947871-26-000546-index-headers.html0000947871-26-000546
Document: 0000947871-26-000546-index.html0000947871-26-000546
Document: 0000947871-26-000546.txt0000947871-26-000546
13 reports for EMBC
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 5 of 5 best @ T+5▲ +13.85%May 5, 2026
Filters
Rows
Reports for EMBC — sortable, filterable
TypeNow
Sep 22, 2026
4w ago
Institutional Cluster
BEARISH ★ 4/10
$5.59 $6.42▼ −14.85%▼ −15.41%$6.64 (−18.69%)
Sep 4, 2026
7w ago
144
NEUTRAL ★ 2/10
$5.80 $5.88▲ +1.38%▲ +0.78%$6.64 (+14.40%)
Aug 13, 2026
10w ago
Insider Cluster
BULLISH ★ 5/10
$5.11 $4.94▼ −3.33%▼ −1.58%$6.64 (+29.84%)
Aug 7, 2026
11w ago
8-K
MIXED ★ 6/10
$4.42 $5.80▲ +31.22%▲ +31.62%$6.64 (+50.11%)
Aug 7, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$4.42 $5.80▲ +31.22%▲ +31.62%$6.64 (+50.11%)
Jul 23, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$3.29 $5.23▲ +58.97%▲ +55.34%$6.64 (+101.67%)
Jun 16, 2026
19w ago
Press Release
NEUTRAL ★ 3/10
$3.09 $3.10▲ +0.32%▲ +0.12%$6.64 (+114.72%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.08 $3.18▲ +3.25%▲ +1.36%$6.64 (+115.42%)
May 15, 2026
23w ago
8-K
MIXED ★ 6/10
$3.14 $3.13▼ −0.32%▼ −2.44%$6.64 (+111.31%)
May 5, 2026
25w ago
8-K
BEARISH ★ 8/10
$3.90 $3.49▲ +10.51%▲ +15.47%$6.64 (−70.13%)
Showing 10 of 13

US Market Status

Market Open — Closes in 3h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 15, 2026